NeoGenomics, Inc. Assets, Noncurrent
NeoGenomics, Inc. (NEO) had Assets, Noncurrent of $970.76 million as of 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:AssetsNoncurrent · last filed 2026-07-28
- 2026-06-30: Assets, Noncurrent $970.76M.
- 2026-03-31: Assets, Noncurrent $972.85M.
- 2025-12-31: Assets, Noncurrent $983.54M.
- 2025-09-30: Assets, Noncurrent $992.32M.
| Period end | Assets, Noncurrent |
|---|---|
| 2026-06-30 | $970.76M 10-Q · filed 2026-07-28 |
| 2026-03-31 | $972.85M 10-Q · filed 2026-04-28 |
| 2025-12-31 | $983.54M 10-Q · filed 2026-07-28 |
| 2025-09-30 | $992.32M 10-Q · filed 2025-10-28 |
| 2025-06-30 | $1.00B 10-Q · filed 2025-07-29 |
| 2025-03-31 | $1.03B 10-Q · filed 2025-04-29 |
| 2024-12-31 | $1.04B 10-K · filed 2026-02-17 |
| 2024-09-30 | $1.05B 10-Q · filed 2024-11-05 |
| 2024-06-30 | $1.06B 10-Q · filed 2024-07-30 |
| 2024-03-31 | $1.07B 10-Q · filed 2024-04-30 |
| 2023-12-31 | $1.08B 10-K · filed 2025-02-18 |
| 2023-09-30 | $1.09B 10-Q · filed 2023-11-06 |
| 2023-06-30 | $1.11B 10-Q · filed 2023-08-08 |
| 2023-03-31 | $1.12B 10-Q · filed 2023-05-09 |
| 2022-12-31 | $1.13B 10-K · filed 2024-02-20 |
| 2022-09-30 | $1.15B 10-Q · filed 2022-11-08 |
| 2022-06-30 | $1.17B 10-Q · filed 2022-08-09 |
| 2022-03-31 | $1.18B 10-Q · filed 2022-05-09 |
| 2021-12-31 | $1.19B 10-K · filed 2023-02-24 |
| 2021-09-30 | $1.20B 10-Q · filed 2021-11-04 |
| 2021-06-30 | $1.17B 10-Q · filed 2021-08-09 |
| 2021-03-31 | $551.68M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $539.60M 10-K · filed 2022-02-25 |
| 2019-12-31 | $418.77M 10-K · filed 2021-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |